OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
By Weiya Zhang, R. Moskowitz, G. Nuki, S. Abramson, R. Altman, N. Arden, S. Bierma-Zeinstra, K. Brandt, Peter Croft, M. Doherty and 6 more. Osteoarthritis and Cartilage, 2008
2,892 citations recorded by the source corpus.
Subfields: Public Health, Environmental and Occupational Health, Rheumatology, Surgery
View Paper: https://www.semanticscholar.org/paper/f51259aa57680bc16fc4676b14af6c28c6754984
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Public Health, Environmental and Occupational Health
In Rheumatology
In Surgery
Citations in the corpus
- Guidance on the management of pain in older people. (2013, methodology): “The practice is supported by several systematic reviews [190– 194] and guidelines [96,98,195], and is refuted by only one review [196].”
- CDC guideline for prescribing opioids for chronic pain (2016, background): “Multiple guidelines recommend NSAIDs as first-line pharmacotherapy for osteoarthritis (83-88) or for low back pain (89); however, NSAIDs and COX-2 inhibitors do have gastrointestinal, renal, and cardiovascular risks.”
- EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis (2013, background): “The group recommended fi ve core interventions to be To be effective, information and education for the person with hip or knee OA should: Ia, mixed 8.4 (7.7 to 9.1) a* be individualised according to the person ’ s illness perceptions and educational capability b* be included in every aspect of…”
- Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial (2009, background): “which may alter the transmission of mechanical forces to the cartilage, possibly increasing its susceptibility to mechanical damage, or wear and tear. Viscosupplementation addresses the degradation of hyaluronic acid (HA) in the synovial fluid of patients with knee osteoarthritis by the addition of ”
- Osteoarthritis: pathogenic signaling pathways and therapeutic targets (2023, background): “In addition, non-pharmacological strategies, including health education, and lifestyle changes, such as diet, postural correction, and self-management, are important measures to prevent OA.(467,468)”
- American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee (2012, background): “OARSI commissioned a systematic review of the literature that updated those conducted for EULAR for OA of the hip and knee.”
- OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. (2019, background): “The full percentage gradient of votes “ in favor ” is displayed alongside the corresponding strata in Supplementary Tables 5, 6, and 7.”